The meeting will be a forum to learn more about new diagnostic tools and techniques. Hotspot testing will be compared to comprehensive genome profiling, emerging technologies will be explored, including molecular test development.
Read More
The findings suggest that these naturally produced mutations are just as powerful as known cancer-causing agents in producing tumors.
Read More
The probes will help identify molecular changes in study samples.
Read More
As a therapeutic target, miR-155 could potentially provide a new avenue of treatment when targeted with drugs to suppress its activity.
Read More
Including p63 in Biocare’s lung, prostate, and breast panels empowers its Multiplex IHC platform to aid pathologists in making critical decisions.
Read More